非酒精性脂肪性肝病诊断标准。
目的观察脂肝清胶囊对非酒精性脂肪性肝病的疗效。
Objective To observe the effect of herbal recipe Zhiganqing capsule (ZGQ capsule) in treating non-alcoholic fatty liver disease (NAFLD).
有研究表明胰岛素抵抗与非酒精性脂肪性肝病密切相关。
Insulin resistance has been shown to be associated with non-alcoholic fatty liver.
目的初步建立并评价蒙古沙鼠非酒精性脂肪性肝病模型。
Objective To establish and evaluate the animal model of nonalcoholic fatty liver disease in Mongolian gerbils.
目的评价胆宁片治疗非酒精性脂肪性肝病（湿热型）的临床疗效。
ObjectiveTo evaluate the therapeutic effect of Danning Tablet (DNT) on patients with non-alcoholic fatty liver (NAFL) of damp-heat Syndrome type.
【译】肥胖儿童非酒精性脂肪性肝病的青少年的左心室功能不全。
Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease.
非酒精性脂肪性肝病(NAFLD)是一种慢性疾病，多种后果。
Nonalcoholic fatty liver disease (NAFLD) is a chronic illness with multiple consequences.
目的：研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
Objetive: To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases (NAFLD).
目的：观察疏肝降浊汤治疗非酒精性脂肪性肝病的临床疗效及安全性。
Objective: To observe the clinical effect and safety of Shugan Jiangzhuo Decoction in treating nonalcoholic fatty liver disease (NAFLD).
这是否反映了非酒精性脂肪性肝病或肝脏的直接血糖损伤，尚无法判断。
Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.
在发达国家，非酒精性脂肪性肝病(NAFLD)是一种很常见的慢性肝脏疾病。
Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in affluent countries.
临床上分为酒精性肝病（ALD）和非酒精性脂肪性肝病（NAFLD）两大类。
The FLD includes alcohol-induced liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD).
【译】适量饮酒降低非酒精性脂肪性肝病的风险：43的175个人的荟萃分析。
Modest alcohol consumption decreases the risk of non-alcoholic fatty liver disease: a meta-analysis of 43 175 individuals.
目的：观察降脂平肝汤对非酒精性脂肪性肝病大鼠胰岛素抵抗的影响，探讨其作用机制。
Objective: to observe the effect of decoction of lowering lipin to calm the liver on insulin resistance of non-alcohol adiposis hepatica rats, and to approach the mechanism of action as well.
近年来，国内外学者对其在非酒精性脂肪性肝病(NAFLD)发生机制中的作用给予高度重视。
More and more attentions have been given to the roles of kupffer cell on the pathogenesis of nonalcoholic liver disease (NAFLD) recently.
事实上，白细胞介素- 1在这种情况下可以诱导肝细胞脂肪沉积，这是非酒精性脂肪性肝病的一个特征。
In fact, interleukin-1 in this scenario can induce fat deposition in the hepatocytes which is one of the characteristics on non-alcoholic fatty liver disease.
我们展示了人类免疫细胞在体外非酒精性脂肪性肝病，说明酒的确影响天然免疫炎症相关的细菌和病毒的感染。
What we showed in human immune cells in vitro petri dish-type alcohol administration is that alcohol indeed affects inflammation and in turn innate immunity related to bacterial and viral infections.
目的探讨非肥胖的糖耐量受损(igt)者的非酒精性脂肪性肝病(NAFLD)与代谢综合征(MS)的关系。
Objective to investigate the relationship between metabolic syndrome (MS) and nonalcoholic fatty liver disease (NAFLD) in non-obese impaired glucose tolerant (IGT) subjects.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的研究罗格列酮联合还原型谷胱甘肽对非酒精性脂肪性肝病（NAFLD）大鼠胰岛素以及胰岛素信号转导相关蛋白表达的影响。
Objective To investigate the effect of rosiglitazone and reduced glutathione on insulin signaling proteins in rats with nonalcoholic fatty liver disease(NAFLD). Methods NAFLD rats were produced.
目的：探讨非酒精性脂肪性肝病(NAFLD)大鼠模型中肝脏线粒体膜流动性的改变以及观察水飞蓟宾对NAFLD的防治作用。
AIM: to explore the effects of silybin on mitochondrial membrane fluidity in the rats with non-alcoholic fatty liver disease (NAFLD).
非酒精性脂肪性肝病与动脉粥样硬化性心血管疾病、2型糖尿病及代 谢综合征临床症候群的关系密切，本文就非酒精性脂肪肝与代谢综合征的关系作一综述。
NAFLD is associated with atherosclerotic cardiovascular disease, type 2 diabetes and the clinical components of MS. We review the relationship between MS and NAFLD in this article.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。非酒精性脂肪肝会导致肝功能衰竭。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis. NAFLD can lead to liver failure.
脂肪性肝病恶化后会很复杂，最严重的是非酒精性脂肪肝炎、肝纤维化、肝硬化。
Fatty liver disease can take many forms that vary in severity, with the most severe being nonalcoholic steatohepatitis (NASH), fibrosis and cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
非酒精性脂肪性肝炎和其他脂肪性肝病的发病机制：四步模型，包括肝硬化进展的脂质释放和肝微梗阻的作用。
The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
应用推荐